ClinicalTrials.gg
Not yet recruitingNCT07439315Updated Nov 16, 2026

The Effect of a Novel Joint Distraction Knee Orthosis for Treating Medial Knee Osteoarthritis

An interventional study of Medial joint distraction brace in Medial Compartment Knee Osteoarthritis, sponsored by Icarus Medical Innovations. Not yet recruiting at 1 site in United States. Open to participants aged 30 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Icarus Medical Innovations · Not applicable, Interventional, and Treatment

How we know

Updated Nov 16, 2026Start date movedPrimary completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Not applicable
Ages
30 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 1,029 studies in Osteoarthritis with a site in United States — 116 open to participants now, 175 under way, 14 of them phase 3. Osteoarthritis · United States.

Planned enrollment
322nd of 832
150 · median 100
Started
2027
the only one that year
No phase
437 of 1,029
54 open now
Primary completion
2027-09
later than 107 of 174 live
Registered
1,012th of 1,029
by date

Among the 1,029 studies in Osteoarthritis with a site in United States, this one is the 322nd largest by planned enrollment of the 832 interventional ones that give a count, is the only one that started in 2027, is one of 437 with no phase, reaches primary completion later than 107 of the 174 other live ones, and was the 1,012th registered.

Osteoarthritis

2,978 studies on the registry are indexed under Osteoarthritis; 438 are open to participants now.

Browse Osteoarthritis studies →

Open to participants now

116 of the 1,029 studies in Osteoarthritis with a site in United States are open now. Recruiting first, the newest first:

111 more — sign in →

All 116 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 285 Osteoarthritis studies recruiting now, 158 (55%) set no upper age limit and 70 (25%) stop at 75 or younger; 22 take children under 18; 31 take healthy volunteers.

This study: 30 Years to 70 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,029 studies in Osteoarthritis with a site in United States, or all of them as a file.
02

Study summary

The Effect of a Novel Joint Distraction Knee Orthosis for Treating Medial Knee Osteoarthritis

03

Conditions studied

  • Medial Compartment Knee Osteoarthritis

Browse trials for

Keywords

  • Knee Brace
  • Osteoarthritis
  • Joint Distraction
04

Who can participate

Ages eligible
30 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 30-70, as significant knee OA is very common for people under 30, and would be more likely correlated to trauma.
  • Able to ambulate with or without assistive devices
  • Body-mass index () under 35. This is to minimize the effect of the variable of how the brace fits on the patient. The finding of pain relief will extrapolate to any BMI.
  • Willingness and ability to comply with scheduled visits and study procedures
  • Willingness and ability to fill out patient questionnaires written in English
  • Ability to provide
  • Clinical diagnosis of medial or lateral compartment knee osteoarthritis requiring a KO.
  • Subject is suitable for unilateral bracing

Exclusion criteria

Exclusion Criteria:

  • Significant cognitive impairment interfering with study assessments
  • Active infections or wounds at the foot or leg
  • Severe spasticity that limits brace fitting or functioning
  • History of severe lower limb deformities that would preclude brace use
  • History of major joint surgery or joint implants, such as total knee replacement
  • Other neurological or musculoskeletal conditions unrelated to the lower limbs that significantly impact gait
  • Non-ambulatory
  • Inability to travel for study procedures or fill out required surveys
  • Medical conditions of interest
  • Pregnant women
  • Prisoners
  • Clinical diagnosis of knee osteoarthritis that is not specific to the knee's medial or lateral compartment (multicompartmental, or patellofemoral knee osteoarthritis)
  • Self-reported pain score of less than 3 out of 10 in the medial compartment.
  • Varus or valgus deformity greater than 12°
  • Inability to read/write/communicate in English
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
150 participants (estimated)

Study arms

  • Experimental
    The Effect of a Novel Joint Distraction Knee Orthosis for Treating Medial Knee Osteoarthritis

    Patients experiencing unicompartment (medial or lateral) osteoarthritis will receive Icarus Adonis Joint Distraction brace. Patients will wear the brace for 12 weeks and document how often they wear the brace and their pain scores. Patients will fill out outcome surveys at 2, 4, 6, 8, and 12 weeks.

    Device: Medial joint distraction brace

Interventions

  • DeviceMedial joint distraction brace

    Patients will receive Icarus Adonis Joint Distraction brace.

06

What researchers measure

Primary outcomes

  1. Knee Injury and Osteoarthritis Outcome Score (KOOS)

    Scored 0 to 100, where 0 represents total knee disability and 100 represents perfect knee

    Time frame: Baseline, 2, 4, 8, 12 weeks

  2. European Quality of Life-5 Dimensions (EQ-5D-5L)

    0 to 1, where 1 is perfect health

    Time frame: Baseline, 2, 4, 8, 12 weeks.

  3. Visual Analogue Scale (VAS)

    0-100, zero meaning no pain, 10 meaning severe pain

    Time frame: Baseline, 2, 4, 8, 12 weeks.

  4. Functional Mobility Assessments

    6 minute walk test

    Time frame: Baseline, 2, 4, 8, 12 weeks

  5. Functional Mobility Assessment

    5 times Sit to Stand test

    Time frame: Baseline, 2, 4, 8, 12 weeks

  6. Functional Mobility Assessment

    Timed Up and Go test

    Time frame: Baseline, 2, 4, 8, 12 weeks

07

Study locations

1 site
  • Icarus Medical Innovations
    Charlottesville, Virginia 22902, United States
08

References and documents

Publications

  • Stetter BJ, Fiedler J, Arndt M, Stein T, Sell S. Impact of a Semi-Rigid Knee Orthotic Intervention on Pain, Physical Activity, and Functional Capacity in Patients with Medial Knee Osteoarthritis. J Clin Med. 2024 Mar 7;13(6):1535. doi: 10.3390/jcm13061535. PubMed 38541761 ↗
  • Cherian JJ, Bhave A, Kapadia BH, Starr R, McElroy MJ, Mont MA. Strength and Functional Improvement Using Pneumatic Brace with Extension Assist for End-Stage Knee Osteoarthritis: A Prospective, Randomized trial. J Arthroplasty. 2015 May;30(5):747-53. doi: 10.1016/j.arth.2014.11.036. Epub 2014 Nov 29. PubMed 25499679 ↗
  • Ciolino JD, Kaizer AM, Bonner LB. Guidance on interim analysis methods in clinical trials. J Clin Transl Sci. 2023 May 15;7(1):e124. doi: 10.1017/cts.2023.552. eCollection 2023. PubMed 37313374 ↗
  • Ayhan E, Kesmezacar H, Akgun I. Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis. World J Orthop. 2014 Jul 18;5(3):351-61. doi: 10.5312/wjo.v5.i3.351. eCollection 2014 Jul 18. PubMed 25035839 ↗
  • Wilder FV, Barrett JP Jr. The association between medication usage and dropout status among participants of an exercise study for people with osteoarthritis. Phys Ther. 2005 Feb;85(2):142-9. PubMed 15679465 ↗
  • Boonstra AM, Schiphorst Preuper HR, Reneman MF, Posthumus JB, Stewart RE. Reliability and validity of the visual analogue scale for disability in patients with chronic musculoskeletal pain. Int J Rehabil Res. 2008 Jun;31(2):165-9. doi: 10.1097/MRR.0b013e3282fc0f93. PubMed 18467932 ↗
  • Roos EM, Lohmander LS. The Knee injury and Osteoarthritis Outcome Score (KOOS): from joint injury to osteoarthritis. Health Qual Life Outcomes. 2003 Nov 3;1:64. doi: 10.1186/1477-7525-1-64. PubMed 14613558 ↗
  • Devlin N, Roudijk B, Ludwig K, editors. Value Sets for EQ-5D-5L: A Compendium, Comparative Review & User Guide [Internet]. Cham (CH): Springer; 2022. No abstract available. Available from http://www.ncbi.nlm.nih.gov/books/NBK589304/ PubMed 36810025 ↗
  • Heinemann AW, Bode RK, O'Reilly C. Development and measurement properties of the Orthotics and Prosthetics Users' Survey (OPUS): a comprehensive set of clinical outcome instruments. Prosthet Orthot Int. 2003 Dec;27(3):191-206. doi: 10.1080/03093640308726682. PubMed 14727700 ↗
  • Balkman GS, Bamer AM, Stevens PM, Weber EL, Morgan SJ, Salem R, Amtmann D, Hafner BJ. Development and initial validation of the Orthotic Patient-Reported Outcomes-Mobility (OPRO-M): An item bank for evaluating mobility of people who use lower-limb orthoses. PLoS One. 2023 Nov 2;18(11):e0293848. doi: 10.1371/journal.pone.0293848. eCollection 2023. PubMed 37917618 ↗
  • Jm B, Pw S, Sa L. Lower Extremity Functional Scale (LEFS).
  • Paluska SA, McKeag DB. Knee braces: current evidence and clinical recommendations for their use. Am Fam Physician. 2000 Jan 15;61(2):411-8, 423-4. PubMed 10670507 ↗
  • Parween R, Shriram D, Mohan RE, Lee YHD, Subburaj K. Methods for evaluating effects of unloader knee braces on joint health: a review. Biomed Eng Lett. 2019 Jan 23;9(2):153-168. doi: 10.1007/s13534-019-00094-z. eCollection 2019 May. PubMed 31168421 ↗
  • DeRogatis M, Anis HK, Sodhi N, Ehiorobo JO, Chughtai M, Bhave A, Mont MA. Non-operative treatment options for knee osteoarthritis. Ann Transl Med. 2019 Oct;7(Suppl 7):S245. doi: 10.21037/atm.2019.06.68. PubMed 31728369 ↗
  • McCormack DJ, Puttock D, Godsiff SP. Medial compartment osteoarthritis of the knee: a review of surgical options. EFORT Open Rev. 2021 Feb 1;6(2):113-117. doi: 10.1302/2058-5241.6.200102. eCollection 2021 Feb. PubMed 33828854 ↗
  • Perdisa F, Bordini B, Salerno M, Traina F, Zaffagnini S, Filardo G. Total Knee Arthroplasty (TKA): When Do the Risks of TKA Overcome the Benefits? Double Risk of Failure in Patients up to 65 Years Old. Cartilage. 2023 Sep;14(3):305-311. doi: 10.1177/19476035231164733. Epub 2023 Apr 19. PubMed 37073516 ↗
  • Franklin PD, Suleiman L, Ibrahim SA. Racial/Ethnic and Sex Differences in Total Knee Arthroplasty Outcomes. JAMA Netw Open. 2020 May 1;3(5):e205000. doi: 10.1001/jamanetworkopen.2020.5000. No abstract available. PubMed 32412633 ↗
  • Wang MC, Chan PH, Paxton EW, Bellows J, Koplan K, Rabrenovich V, Convissar J, Reddy NC, Grimsrud CD, Navarro RA. Factors Influencing Patient Satisfaction With Care and Surgical Outcomes for Total Hip and Knee Replacement. Perm J. 2021 Nov 3;25:21.043. doi: 10.7812/TPP/21.043. PubMed 35348097 ↗
  • Goodman SM, Mehta B, Zhang M, Szymonifka J, Nguyen JT, Lee L, Figgie MP, Parks ML, Dey SA, Crego D, Russell LA, Mandl LA, Bass AR. Disparities in Total Hip Arthroplasty Outcomes: Census Tract Data Show Interactions Between Race and Community Deprivation. J Am Acad Orthop Surg. 2018 Nov 1;26(21):e457-e464. doi: 10.5435/JAAOS-D-17-00393. PubMed 30192253 ↗
  • Chun DS, Leonard AK, Enchill Z, Suleiman LI. Racial Disparities in Total Joint Arthroplasty. Curr Rev Musculoskelet Med. 2021 Dec;14(6):434-440. doi: 10.1007/s12178-021-09718-3. Epub 2021 Oct 9. PubMed 34626322 ↗
  • Losina E, Paltiel AD, Weinstein AM, Yelin E, Hunter DJ, Chen SP, Klara K, Suter LG, Solomon DH, Burbine SA, Walensky RP, Katz JN. Lifetime medical costs of knee osteoarthritis management in the United States: impact of extending indications for total knee arthroplasty. Arthritis Care Res (Hoboken). 2015 Feb;67(2):203-15. doi: 10.1002/acr.22412. PubMed 25048053 ↗
  • Ezomo OT, Sun D, Gronbeck C, Harrington MA, Halawi MJ. Where Do We Stand Today on Racial and Ethnic Health Disparities? An Analysis of Primary Total Hip Arthroplasty From a 2011-2017 National Database. Arthroplast Today. 2020 Nov 2;6(4):872-876. doi: 10.1016/j.artd.2020.10.002. eCollection 2020 Dec. PubMed 33163602 ↗
  • Segal NA. Bracing and orthoses: a review of efficacy and mechanical effects for tibiofemoral osteoarthritis. PM R. 2012 May;4(5 Suppl):S89-96. doi: 10.1016/j.pmrj.2012.01.018. PubMed 22632708 ↗
  • Long H, Liu Q, Yin H, Wang K, Diao N, Zhang Y, Lin J, Guo A. Prevalence Trends of Site-Specific Osteoarthritis From 1990 to 2019: Findings From the Global Burden of Disease Study 2019. Arthritis Rheumatol. 2022 Jul;74(7):1172-1183. doi: 10.1002/art.42089. Epub 2022 Jun 2. PubMed 35233975 ↗
  • Alam M, Choudhury IA, Bin Mamat A. Mechanism and design analysis of articulated ankle foot orthoses for drop-foot. ScientificWorldJournal. 2014;2014:867869. doi: 10.1155/2014/867869. Epub 2014 Apr 30. PubMed 24892102 ↗
  • Nori SL, Stretanski MF. Foot Drop. In: StatPearls. StatPearls Publishing; 2024. Accessed September 24, 2024. http://www.ncbi.nlm.nih.gov/books/NBK554393/
  • Kobayashi E, Hiratsuka K, Haruna H, Kojima N, Himuro N. Efficacy of Knee-Ankle-Foot Orthosis on Functional Mobility and Activities of Daily Living in Patients with Stroke: A Systematic Review of Case Reports. J Rehabil Med. 2022 Jul 7;54:jrm00290. doi: 10.2340/jrm.v54.87. PubMed 35582910 ↗
  • Bashir AZ, Dinkel DM, Pipinos II, Johanning JM, Myers SA. Patient Compliance With Wearing Lower Limb Assistive Devices: A Scoping Review. J Manipulative Physiol Ther. 2022 Feb;45(2):114-126. doi: 10.1016/j.jmpt.2022.04.003. Epub 2022 Jun 24. PubMed 35753880 ↗

Individual participant data

Plan to share: Undecided — IPD must be deidentified according to UVA IRB standard. If this would be the case then we would plan to share IPD and publish this study.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2027; primary completion for Sep 2027, 8 months later.

Of 135 industry-sponsored interventional studies with no phase under Osteoarthritis, half reached primary completion within 38 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 81. This study's planned 8 months is below that.

Counting every sponsor, half of 713 studies reached it within 28 months; a quarter within 11 and three quarters within 57.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 16, 2026: start Mar 2026 → Jan 2027, primary completion Jun 2026 → Sep 2027 and completion Aug 2026 → Dec 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 18, 2026
First posted
Feb 27, 2026
StartEst.
Jan 1, 2027was Mar 2026
Primary completionEst.
Sep 1, 2027was Jun 2026
CompletionEst.
Dec 1, 2027was Aug 2026
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Mar 1, 2026→Jan 1, 2027
Nov 16, 2026
Primary completion
Jun 1, 2026→Sep 1, 2027
Nov 16, 2026
Study completion
Aug 1, 2026→Dec 1, 2027
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    Start date Mar 1, 2026→Jan 1, 2027
    Primary completion Jun 1, 2026→Sep 1, 2027
    Study completion Aug 1, 2026→Dec 1, 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07439315
Lead sponsor
Icarus Medical Innovations
Responsible party
Sponsor
First posted
Feb 27, 2026
Start date
Jan 1, 2027 (estimated)
Primary completion
Sep 1, 2027 (estimated)
Completion
Dec 1, 2027 (estimated)
Last update
Nov 16, 2026

Study contacts

Benjamin M Koerber, PhD
Contact
benk@icarusmedical.com
8147909364
Evan Eckersley
Contact
evan@icarusmedical.com
(570) 955-9662

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion